X-Health.show - meet the future of healthcare

Single-Cell Technologies to Accelerate Drug Development and Cancer Treatment: Dr. Diana Stoycheva, Scailyte

June 06, 2023 Alex: interviewing visionaries of healthcare innovation
Single-Cell Technologies to Accelerate Drug Development and Cancer Treatment: Dr. Diana Stoycheva, Scailyte
X-Health.show - meet the future of healthcare
More Info
X-Health.show - meet the future of healthcare
Single-Cell Technologies to Accelerate Drug Development and Cancer Treatment: Dr. Diana Stoycheva, Scailyte
Jun 06, 2023
Alex: interviewing visionaries of healthcare innovation

They are great soldiers.

They go after every rouge cell they can find. And kill it.

And they never forget the enemies, always ready to fight back.

We're speaking cancer treatment of the future, in clinical trials today – but not only. Single-cell analysis can serve personalized medicine, in various diseases.

You’ll hear about cell therapy to fight cancer, CAR T cell therapy, precision medicine and training cells in killing rougue cells, multiomics analysis, drug discovery powered and accelerated by AI, and coming soon: early biomarkers for endometriosis.

Dr. Diana Stoycheva is a Principal Expert Scientist at Scailyte. She specializes in immunology, infectious diseases, and immuno-oncology. 

Scailyte, the company she joined, developed an Artificial Intelligence driven platform that supports discovery of complex disease patterns from single-cell data. They’re at the forefront of advancing precision medicine through AI and multiomics analysis.

Find them at https://scailyte.com.


If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.

The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.

Show Notes Chapter Markers

They are great soldiers.

They go after every rouge cell they can find. And kill it.

And they never forget the enemies, always ready to fight back.

We're speaking cancer treatment of the future, in clinical trials today – but not only. Single-cell analysis can serve personalized medicine, in various diseases.

You’ll hear about cell therapy to fight cancer, CAR T cell therapy, precision medicine and training cells in killing rougue cells, multiomics analysis, drug discovery powered and accelerated by AI, and coming soon: early biomarkers for endometriosis.

Dr. Diana Stoycheva is a Principal Expert Scientist at Scailyte. She specializes in immunology, infectious diseases, and immuno-oncology. 

Scailyte, the company she joined, developed an Artificial Intelligence driven platform that supports discovery of complex disease patterns from single-cell data. They’re at the forefront of advancing precision medicine through AI and multiomics analysis.

Find them at https://scailyte.com.


If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.

The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.

Dr Diana Stoycheva and Scailyte - intro
Single-cell technologies
What are multiomics
ScaiVision platform
Predicting a patient's response to therapy
Teaching AI
For drug developers and those who generate complex data
Founding Scailyte startup
Dr. Stoycheva's background in immunology and immuno-oncology
Potential of immunotherapy in treating cancer
Cell therapy
CAR T cells
CAR T cell therapy efficacy
Singe-cell technologies adoption
Scailyte-Turnstone Biologics partnership
How to learn max from early stage trial
Predictive biomarkers and CDx
Market access
Biomarkers for precision medicine
Cost of personalized cancer treatment
Future of single-cell data analysis
Early biomarkers for endometriosis
Links to Scailyte, Follow X-Health.show, Disclaimer